Cutler Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$57K 5547
2022
Q3
$57K Sell
200
-150
-43% -$43.2K 0.01% 1799
2022
Q2
$98K Buy
+350
New +$93.7K 0.01% 1457
2022
Q1
Sell
-2,040
Closed -$484K 6403
2021
Q4
$447K Sell
2,040
-1,610
-44% -$313K 0.03% 809
2021
Q3
$662K Hold
3,650
0.05% 646
2021
Q2
$735K Sell
3,650
-1,250
-26% -$261K 0.05% 585
2021
Q1
$1.05M Buy
+4,900
New +$1.08M 0.09% 420
2020
Q2
Sell
-900
Closed -$244K 5331
2020
Q1
$214K Sell
900
-2,120
-70% -$486K 0.02% 912
2019
Q4
$661K Sell
3,020
-900
-23% -$182K 0.05% 357
2019
Q3
$664K Sell
3,920
-400
-9% -$70.8K 0.08% 286
2019
Q2
$792K Buy
4,320
+3,800
+731% +$664K 0.09% 233
2019
Q1
$95K Sell
520
-300
-37% -$55.4K 0.01% 1030
2018
Q4
$135K Hold
820
0.02% 861
2018
Q3
$158K Hold
820
0.01% 950
2018
Q2
$139K Buy
820
+720
+720% +$112K 0.01% 946
2018
Q1
$16K Sell
100
-27,397
-100% -$4.47M ﹤0.01% 2455
2017
Q4
$4.12M Sell
27,497
-16,991
-38% -$2.52M 0.21% 73
2017
Q3
$6.76M Buy
44,488
+30,259
+213% +$4.55M 0.32% 50
2017
Q2
$1.83M Buy
14,229
+11,204
+370% +$1.35M 0.09% 238
2017
Q1
$330K Sell
3,025
-17,076
-85% -$1.5M 0.02% 860
2016
Q4
$1.48M Buy
20,101
+5,340
+36% +$435K 0.07% 278
2016
Q3
$1.29M Buy
14,761
+13,261
+884% +$1.25M 0.08% 244
2016
Q2
$129K Sell
1,500
-1,273
-46% -$110K 0.01% 1478
2016
Q1
$220K Sell
2,773
-5,931
-68% -$536K 0.02% 956
2015
Q4
$1.09M Buy
+8,704
New +$1.05M 0.09% 315

Other funds holding VRTX